The triple-action shot hits GLP-1, GIP and glucagon receptors. Trial results also pointed to other health improvements beyond the weight loss figure.
Recap by typeshit. Post by Facebook on Facebook.
The digital health doctor shares a take on GLP-1 therapy paired with lifestyle change and digital programs, calling the finding unsurprising.
A Facebook post says US researchers found pancreatic cells producing GLP-1 on their own. It frames this as a possible built-in appetite and sugar control system, without naming the study.
Researchers are studying whether GLP-1 drugs, which act on mood, appetite and reward pathways, could help with depression, addiction and binge eating.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
With millions now getting GLP-1 care online, U.S. News sizes up the telehealth services competing in this fast-growing market.
A short post explains what people online mean by GLP-1 microdosing, taking doses below the approved levels, and notes none of it is FDA-sanctioned.
Loading…